Agenus Inc.

AGEN ·Healthcare, Drug Manufacturers - General, United States
Financial Statements › Balance Sheet
Annual Quarterly

Balance Sheet

Line Item FY2025 FY2024 FY2023 FY2022 FY2021 FY2020 FY2019 FY2018
Assets
Cash & Equivalents $3.0M $40.4M $76.1M $178.7M $291.9M $99.9M $61.8M $53.1M
Accounts Receivable $1.8M $407.0K $25.8M $2.7M $1.5M $1.2M $16.3M $938.0K
Inventory — — — — — — $0 $55.0K
Total Current Assets $133.4M $45.6M $112.4M $213.1M $332.0M $113.8M $86.5M $74.8M
Property, Plant & Equipment $15.5M $120.1M $133.4M $133.0M $60.0M $26.8M $26.3M $25.1M
Goodwill $24.1M $24.1M $24.7M $25.5M $24.9M $25.5M $23.2M $22.9M
Intangible Assets (Excl. Goodwill) $3.0M $3.4M $4.4M $6.2M $8.5M $10.9M $10.5M $12.3M
Total Assets $226.8M $226.3M $313.9M $413.6M $466.0M $214.5M $155.3M $136.4M
Liabilities
Accounts Payable $83.0M $61.5M $61.4M $40.9M $30.5M $17.0M $13.6M $13.6M
Total Current Liabilities $323.5M $221.4M $255.9M $189.0M $156.9M $129.9M $122.2M $68.1M
Long-Term Debt $0 $30.5M $12.8M $12.6M $12.8M $18.9M $13.4M $13.2M
Total Liabilities $497.9M $552.7M $474.2M $474.8M $431.5M $418.2M $380.7M $308.9M
Stockholders' Equity
Retained Earnings $-2.18B $-2.18B $-1.96B $-1.71B $-1.49B $-1.47B $-1.28B $-1.18B
Total Stockholders' Equity $-271.1M $-326.4M $-160.3M $-61.3M $34.4M $-203.7M $-225.4M $-172.5M
← Newer Page 1 of 2 Older →